tradingkey.logo
tradingkey.logo
Search

Tandem Diabetes Care Inc

TNDM
Add to Watchlist
19.500USD
+0.490+2.58%
Close 07-31 16:00ETQuotes delayed by 15 min
1.34BMarket Cap
LossP/E TTM

Tandem Diabetes Care Inc

19.500
+0.490+2.58%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+2.58%

5 Days

+13.90%

1 Month

+27.28%

6 Months

-2.94%

Year to Date

-11.28%

1 Year

+26.62%

Key Figures
19.100Open
19.660High
1.83MVolume
LossP/E TTM
157.75P/E Dynamic
--Dividend TTM
2.69%Turnover Ratio
19.010Prev. Close
18.560Low
27.20MTurnover
LossP/E Static
8.58P/B
0.00%Div Yield TTM
-9.11%ROA
29.65052wk High
0.99Volume Ratio
-96.03MNet Profit
68.29MShares
-1.3745EPS TTM
1.59Beta
-65.73%ROE
9.98052wk Low
5.79%Amplitude
55.33%Gross Margin
1.34BMarket Cap
5.75Reward/Risk
4.05%Risk Rate

Key Insights

Tandem Diabetes Care Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 49 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.97.In the medium term, the stock price is expected to remain stable.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tandem Diabetes Care Inc's Score

Industry at a Glance

Industry Ranking
49 / 199
Overall Ranking
114 / 4281
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Tandem Diabetes Care Inc Highlights

StrengthsRisks
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 35.71% year-on-year.
Fairly Valued
The company’s latest PE is -14.19, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 88.22M shares, decreasing 10.14% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 900.81K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.14.

Analyst Rating

Based on 22 analysts
Buy
Current Rating
28.974
Target Price
+48.58%
Upside Space

Tandem Diabetes Care Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 22 analysts
Buy
Current Rating
28.974
Target Price
+48.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Tandem Diabetes Care Inc
TNDM
22
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22

Indicators

Indicators
Sell(1)
Neutral(1)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.652
Buy
RSI(14)
68.464
Neutral
STOCH(KDJ)(9,3,3)
93.764
Overbought
ATR(14)
1.096
Low Volatility
CCI(14)
157.253
Buy
Williams %R
3.147
Overbought
TRIX(12,20)
0.573
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
18.406
Buy
MA10
17.866
Buy
MA20
16.794
Buy
MA50
16.522
Buy
MA100
18.122
Buy
MA200
19.011
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Tandem Diabetes Care Inc Info

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Ticker SymbolTNDM
CompanyTandem Diabetes Care Inc
CEOSheridan (John F)
Websitehttps://www.tandemdiabetes.com/

Shareholders

Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.31%
Sessa Capital
7.30%
Vanguard Portfolio Management, LLC
5.83%
Vanguard Capital Management, LLC
4.43%
ArrowMark Colorado Holdings, LLC
4.22%
Other
63.92%

FAQs

What is the current price of Tandem Diabetes Care Inc (TNDM)?

The current price of Tandem Diabetes Care Inc (TNDM) is 19.50.

What is the symbol of Tandem Diabetes Care Inc?

The ticker symbol of Tandem Diabetes Care Inc is TNDM.

What is the 52-week high of Tandem Diabetes Care Inc?

The 52-week high of Tandem Diabetes Care Inc is 29.65.

What is the 52-week low of Tandem Diabetes Care Inc?

The 52-week low of Tandem Diabetes Care Inc is 9.98.

What is the market capitalization of Tandem Diabetes Care Inc?

The market capitalization of Tandem Diabetes Care Inc is 1.34B.

Is Tandem Diabetes Care Inc (TNDM) currently rated as Buy, Hold, or Sell?

According to analysts, Tandem Diabetes Care Inc (TNDM) has an overall rating of Buy, with a price target of 28.97.

What is the Earnings Per Share (EPS TTM) of Tandem Diabetes Care Inc (TNDM)?

The Earnings Per Share (EPS TTM) of Tandem Diabetes Care Inc (TNDM) is -3.04.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.